Hormonal Contraceptives Market by Method and Geography - Forecast and Analysis 2022-2026

Published: Feb 2022 Pages: 120 SKU: IRTNTR72277

The hormonal contraceptive market share is expected to increase by USD 5.24 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.30%.

This hormonal contraceptives market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers hormonal contraceptives market segmentation by method (oral contraceptives, implanted contraceptives, injected contraceptives, intrauterine, and others) and geography (North America, Asia, Europe, and ROW). The hormonal contraceptives market report also offers information on several market vendors, including AbbVie Inc., Afaxys Pharma LLC, Bayer AG, HLL Lifecare Ltd., Johnson and Johnson Inc., Lupin Ltd., Merck and Co. Inc., Mylan NV, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. among others.

What will the Hormonal Contraceptives Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Hormonal Contraceptives Market Size for the Forecast Period and Other Important Statistics

Hormonal methods of birth control (contraception) contain either estrogen and progestin or progestin-only they are a safe and reliable way to prevent pregnancy for most people. Hormonal methods include an implant, an intrauterine device (IUD), injections, pills, vaginal rings, and skin patches. It is be taken in mouth, injected or inserted under the skin, placed on the skin as a patch, or placed in the vagina or uterus.

Hormonal Contraceptives Market: Key Drivers, Trends, and Challenges

The increase in unplanned pregnancies is notably driving the hormonal contraceptives market growth, although factors such as lack of social acceptance may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the hormonal contraceptives industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Hormonal Contraceptives Market Driver

One of the key factors driving the global hormonal contraceptives market growth is the increase in unplanned pregnancies. Governments worldwide have been making efforts to tackle the issue of unplanned pregnancies, but their initiatives have been undermined by public healthcare cuts. Also, the rising prevalence of unprotected sex among the young generation has increased the number of unplanned pregnancies. Furthermore, in the case of an unplanned pregnancy, a woman may not be in optimal health for childbearing and eventually child-rearing, thus affecting the health of the baby. For instance, between 2015 and 2020, globally, there were 121 million unintended pregnancies annually, corresponding to a global rate of 64 pregnancies per 1,000 women aged 15-49 years. With the rise in the number of unplanned pregnancies, the demand for hormonal contraceptives is expected to increase, thus propelling sales for vendors and leading to market growth.

Key Hormonal Contraceptives Market Trend

Another key factor driving the global hormonal contraceptives market growth is the growing awareness about the importance of family planning in developing countries. Voluntary family planning has been widely adopted across the world through the efforts of the media and governments. Organizations like the Asia-Pacific Council on Contraception, the European Society of Cardiology, and the International Planned Parenthood Federation conduct programs to spread awareness about contraceptives, such as hormonal contraceptives worldwide. However, in developing countries, there is a huge unmet need for contraception. Thus, the market is expected to grow during the forecast period, which will be further supported by government initiatives that promote family planning and provide women with easy access to contraceptives.

Key Hormonal Contraceptives Market Challenge

One of the key challenges to the global hormonal contraceptives market growth is the lack of social acceptance due to stereotypes. The perception of society dissuades people from buying these products. Most societies, due to their religious values, believe hormonal contraceptives to be immoral and unethical. Although the emergence of e-commerce has helped overcome this hurdle, as it provides buyers anonymity, the perception of the society remains the same. Such factors will affect the sales of hormonal contraceptives, which will impact the growth of the market in focus during the forecast period.

This hormonal contraceptives market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global hormonal contraceptives market as a part of the global pharmaceutical market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the hormonal contraceptives market during the forecast period.

Who are the Major Hormonal Contraceptives Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

  • AbbVie Inc.
  • Afaxys Pharma LLC
  • Bayer AG
  • HLL Lifecare Ltd.
  • Johnson and Johnson Inc.
  • Lupin Ltd.
  • Merck and Co. Inc.
  • Mylan NV
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.

This statistical study of the hormonal contraceptives market encompasses successful business strategies deployed by the key vendors. The hormonal contraceptives market is fragmented and the vendors are deploying growth strategies such as investment in R&D and product innovation to compete in the market.

Product Insights and News

  • AbbVie Inc. - The company offers hormonal contraceptives that include products such as pharmaceutical drugs Humira, Imbruvica, Venclexta, Zinbryta, Kaletra, Norvir, Mavyret, Skyrizi, and Rinvoq

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The hormonal contraceptives market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Hormonal Contraceptives Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the hormonal contraceptives market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chains is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

The value chain of the global pharmaceutical market includes the following core components:

  • Research and development (R&D) and drug discovery
  • Inbound logistics
  • Integration and product development
  • Manufacturing
  • Outbound logistics
  • Marketing and sales
  • Support activities
  • Innovation

The report has further elucidated on other innovative approaches being followed by manufacturers to ensure a sustainable market presence.

Which are the Key Regions for Hormonal Contraceptives Market?

For more insights on the market share of various regions Request for a FREE sample now!

34% of the market's growth will originate from North America during the forecast period. Mexico, the US, Dominican Republic, and Canada are the key markets for hormonal contraceptives in North America. Market growth in this region will be slower than the growth of the market in Europe and Asia.

The presence of local market players, supportive government policies, and technological innovations will facilitate the hormonal contraceptives market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

In 2020, the outbreak of COVID-19 affected all countries in North America. A rise in the number of COVID-19 cases in the first quarter of 2020 led to partial lockdowns in several countries, including Canada and Mexico. Hence, the adoption of some hormonal contraceptives, including related procedures, and the availability of prescription drugs reduced slightly, which impacted market growth in 2020 and in Q1 of 2021 to some extent. However, by the second half of 2020, most of the restrictions in various countries had been relaxed to some extent, which allowed business activities and essential services, including the sales of OTC contraceptives, to resume. The relaxation of such restrictions has encouraged people to go for health checkups and treatments, which will drive the growth of the hormonal contraceptives market in North America during the forecast period.

What are the Revenue-generating Method Segments in the Hormonal Contraceptives Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The hormonal contraceptive market share growth by the oral contraceptives segment will be significant during the forecast period. The high demand for oral contraceptives will drive the market growth through this segment. Approximately 25% of women aged 15 to 44 who currently use contraception prefer using the birth control pill as their method of choice. 

This report provides an accurate prediction of the contribution of all the segments to the growth of the hormonal contraceptives market size and actionable market insights on post COVID-19 impact on each segment.

Hormonal Contraceptives Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 5.30%

Market growth 2022-2026

$ 5.24 billion

Market structure

Fragmented

YoY growth (%)

3.74

Regional analysis

North America, Asia, Europe, and ROW

Performing market contribution

North America at 34%

Key consumer countries

Mexico, US, Dominican Republic, India, and Canada

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

AbbVie Inc., Afaxys Pharma LLC, Bayer AG, HLL Lifecare Ltd., Johnson and Johnson Inc., Lupin Ltd., Merck and Co. Inc., Mylan NV, Pfizer Inc., and Teva Pharmaceutical Industries Ltd.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Hormonal Contraceptives Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive hormonal contraceptives market growth during the next five years
  • Precise estimation of the hormonal contraceptives market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the hormonal contraceptives industry across North America, Asia, Europe, and ROW
  • A thorough analysis of the market's competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of hormonal contraceptives market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

***1. Executive Summary                           

                **1.1 Market Overview

                                *Exhibit 01:  Key Finding 1

                                *Exhibit 02:  Key finding 2

                                *Exhibit 03:  Key finding 3

                                *Exhibit 04:  Key finding 5

                                *Exhibit 05:  Key finding 6

                                *Exhibit 06:  Key finding 7

                                *Exhibit 07:  Key finding 8

***2. Market Landscape                             

                **2.1 Market ecosystem             

                                *2.1.1 Parent market

                                *Exhibit 08:  Parent market

                                *Exhibit 09:  Market characteristics

                **2.2 Value chain analysis           

                                *Exhibit 10:  Value chain analysis: Electronic equipment and instruments

                                *2.2.1 Research and development (R&D) and drug discovery

                                *2.2.2 Integration and product development

                                *2.2.3 Manufacturing

                                *2.2.4 Outbound logistic

                                *2.2.5 Marketing and sales

                                *2.2.6 Support services

                                *2.2.7 Innovation

***3. Market Sizing                       

                **3.1 Market definition

                                *Exhibit 11:  Offerings of vendors included in the market definition

                **3.2 Market segment analysis 

                                *Exhibit 12:  Market segments

                **3.3 Market size 2021 

                **3.4 Market outlook: Forecast for 2021 - 2026 

                                *3.4.1 Estimating growth rates for emerging and high-growth markets

                                *3.4.2 Estimating growth rates for mature markets

                                *Exhibit 13:  Global - Market size and forecast 2021 - 2026 ($ million)

                                *Exhibit 14:  Global market: Year-over-year growth 2021 - 2026 (%)

***4. Five Forces Analysis                          

                **4.1 Five Forces Summary        

                                *Exhibit 15:  Five forces analysis 2021 & 2026

                **4.2 Bargaining power of buyers           

                                *Exhibit 16:  Bargaining power of buyers

                **4.3 Bargaining power of suppliers       

                                *Exhibit 17: Bargaining power of suppliers

                **4.4 Threat of new entrants    

                                *Exhibit 18:  Threat of new entrants

                **4.5 Threat of substitutes         

                                *Exhibit 19: Threat of substitutes

                **4.6 Threat of rivalry   

                                *Exhibit 20: Threat of rivalry

                **4.7 Market condition

                                *Exhibit 21:  Market condition - Five forces 2021

***5. Market Segmentation by Method                              

                **5.1 Market segments

                                *The segments covered in this chapter are:

  • Oral contraceptives
  • Implanted contraceptives
  • Injected contraceptives
  • Intrauterine
  • Others

                                *Exhibit 22:  Method - Market share 2021-2026 (%)

                **5.2 Comparison by Method   

                                *Exhibit 23:  Comparison by Method

                **5.3 Oral contraceptives - Market size and forecast 2021-2026  

                                *Exhibit 24:  Oral contraceptives - Market size and forecast 2021-2026 ($ million)

                                *Exhibit 25:  Oral contraceptives - Year-over-year growth 2021-2026 (%)

                **5.4 Implanted contraceptives - Market size and forecast 2021-2026      

                                *Exhibit 26:  Implanted contraceptives - Market size and forecast 2021-2026 ($ million)

                                *Exhibit 27:  Implanted contraceptives - Year-over-year growth 2021-2026 (%)

                **5.5 Injected contraceptives - Market size and forecast 2021-2026          

                                *Exhibit 28:  Injected contraceptives - Market size and forecast 2021-2026 ($ million)

                                *Exhibit 29:  Injected contraceptives - Year-over-year growth 2021-2026 (%)

                **5.6 Intrauterine - Market size and forecast 2021-2026 

                                *Exhibit 30:  Intrauterine - Market size and forecast 2021-2026 ($ million)

                                *Exhibit 31:  Intrauterine - Year-over-year growth 2021-2026 (%)

                **5.7 Others - Market size and forecast 2021-2026           

                                *Exhibit 32:  Others - Market size and forecast 2021-2026 ($ million)

                                *Exhibit 33:  Others - Year-over-year growth 2021-2026 (%)

                **5.8 Market opportunity by Method    

                                *Exhibit 34:  Market opportunity by Method

***6. Customer landscape                         

                                *Technavio’s customer landscape matrix comparing Drivers or price sensitivity, Adoption lifecycle, importance in customer price basket, Adoption rate and Key purchase criteria

                **6.1 Customer landscape          

                                *Exhibit 35:  Customer landscape

***7. Geographic Landscape                     

                **7.1 Geographic segmentation

                                *The regions covered in the report are:

  • North America
  • Asia
  • Europe
  • ROW

                                *Exhibit 36:  Market share by geography 2021-2026 (%)

                **7.2 Geographic comparison   

                                *Exhibit 37:  Geographic comparison

                **7.3 North America - Market size and forecast 2021-2026           

                                *Exhibit 38:  North America - Market size and forecast 2021-2026 ($ million)

                                *Exhibit 39:  North America - Year-over-year growth 2021-2026 (%)

                **7.4 Asia - Market size and forecast 2021-2026

                                *Exhibit 40:  Asia - Market size and forecast 2021-2026 ($ million)

                                *Exhibit 41:  Asia - Year-over-year growth 2021-2026 (%)

                **7.5 Europe - Market size and forecast 2021-2026          

                                *Exhibit 42:  Europe - Market size and forecast 2021-2026 ($ million)

                                *Exhibit 43:  Europe - Year-over-year growth 2021-2026 (%)

                **7.6 ROW - Market size and forecast 2021-2026              

                                *Exhibit 44:  ROW - Market size and forecast 2021-2026 ($ million)

                                *Exhibit 45:  ROW - Year-over-year growth 2021-2026 (%)

                **7.7 Key leading countries        

                                *Exhibit 46:  Key leading countries

                **7.8 Market opportunity by geography

                                *Exhibit 47:  Market opportunity by geography ($ million)

***8. Drivers, Challenges, and Trends                   

                **8.1 Market drivers     

                                *8.1.1 Increase in unplanned pregnancies

                                *8.1.2 Initiatives by government and non-profit organizations

                                *8.1.3    Increasing adoption of innovative marketing strategies

                **8.2 Market challenges              

                                *8.2.1 Lack of social acceptance

                                *8.2.2 Disparities with regard to sex education in developed countries

                                *8.2.3 Lack of reimbursement

                                *Exhibit 48:  Impact of drivers and challenges

                **8.3 Market trends      

                                *8.3.1 Importance of family planning in developing countries

                                *8.3.2 Rising disposable income

                                *8.3.3 Technological advances

***9. Vendor Landscape                             

                **9.1 Overview

                                *Exhibit 49:  Vendor landscape

                **9.2 Landscape disruption        

                                *Exhibit 50:  Landscape disruption

                                *Exhibit 51:  Industry risks

                **9.3 Competitive landscape     

***10. Vendor Analysis               

                **10.1 Vendors covered              

                                *Exhibit 52:  Vendors covered

                **10.2 Market positioning of vendors    

                                *Exhibit 53: Market positioning of vendors

                **10.3 AbbVie Inc.         

                                *Exhibit 54:  AbbVie Inc. - Overview

                                *Exhibit 55:  AbbVie Inc. - Business segments

                                *Exhibit 56:  AbbVie Inc. - Key offerings

                                *Exhibit 57:  AbbVie Inc. - Segment focus

                **10.4 Afaxys Pharma LLC           

                                *Exhibit 58:  Afaxys Pharma LLC - Overview

                                *Exhibit 59:  Afaxys Pharma LLC - Product and service

                                *Exhibit 60:  Afaxys Pharma LLC - Key offerings

                **10.5 Bayer AG             

                                *Exhibit 61:  Bayer AG - Overview

                                *Exhibit 62:  Bayer AG - Business segments

                                *Exhibit 63:  Bayer AG - Key offerings

                                *Exhibit 64:  Bayer AG - Segment focus

                **10.6 HLL Lifecare Ltd.

                                *Exhibit 65:  HLL Lifecare Ltd. - Overview

                                *Exhibit 66:  HLL Lifecare Ltd. - Product and service

                                *Exhibit 67:  HLL Lifecare Ltd. - Key offerings

                **10.7 Johnson and Johnson Inc.              

                                *Exhibit 68:  Johnson and Johnson Inc.  - Overview

                                *Exhibit 69:  Johnson and Johnson Inc.  - Business segments

                                *Exhibit 70:  Johnson and Johnson Inc.  - Key offerings

                                *Exhibit 71:  Johnson and Johnson Inc.  - Segment focus

                *10.8 Lupin Ltd.

                                *Exhibit 72:  Lupin Ltd. - Overview

                                *Exhibit 73:  Lupin Ltd. - Product and service

                                *Exhibit 74:  Lupin Ltd. - Key offerings

                **10.9 Merck and Co. Inc.           

                                *Exhibit 75:  Merck and Co. Inc. - Overview

                                *Exhibit 76:  Merck and Co. Inc. - Business segments

                                *Exhibit 77:  Merck and Co. Inc. - Key offerings

                                *Exhibit 78:  Merck and Co. Inc. - Segment focus

                **10.10 Mylan NV          

                                *Exhibit 79:  Mylan NV - Overview

                                *Exhibit 80:  Mylan NV - Business segments

                                *Exhibit 81:  Mylan NV - Key offerings

                                *Exhibit 82:  Mylan NV - Segment focus

                **10.11 Pfizer Inc.          

                                *Exhibit 83:  Pfizer Inc. - Overview

                                *Exhibit 84:  Pfizer Inc. - Key offerings

                                *Exhibit 85:  Pfizer Inc. - Segment focus

                **10.12 Teva Pharmaceutical Industries Ltd.       

                                *Exhibit 86:  Teva Pharmaceutical Industries Ltd. - Overview

                                *Exhibit 87:  Teva Pharmaceutical Industries Ltd. - Business segments

                                *Exhibit 88:  Teva Pharmaceutical Industries Ltd. - Key offerings

                                *Exhibit 89:  Teva Pharmaceutical Industries Ltd. - Segment focus

***11. Appendix                            

                **11.1 Scope of the report         

                                *11.1.1 Market definition

                                *11.1.2 Objectives

                                *11.1.3 Notes and caveats

                **11.2 Currency conversion rates for US$            

                                *Exhibit 90:  Currency conversion rates for US$

                **11.3 Research Methodology 

                                *Exhibit 91:  Research Methodology

                                *Exhibit 92:  Validation techniques employed for market sizing

                                *Exhibit 93:  Information sources

                **11.4 List of abbreviations        

                                *Exhibit 94:  List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

PURCHASE FULL REPORT OF

hormonal contraceptives market

QUICK BUY

Key Questions Answered

  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis